1.
Sustained Therapeutic Reversal of Huntington's Disease by Transient Repression of Huntingtin Synthesis
by Kordasiewicz, Holly B
Neuron (Cambridge, Mass.), 2012-06-21, Vol.74 (6), p.1031-1044
2.
Role of Axonal Transport in Neurodegenerative Diseases
by DE VOS, Kurt J
Annual review of neuroscience, 2008, Vol.31 (1), p.151-173
3.
Allele-selective transcriptional repression of mutant HTT for the treatment of Huntington's disease
by Zeitler, Bryan
Nature medicine, 2019-07, Vol.25 (7), p.1131-1142
4.
Huntington's Disease: Can Mice Lead the Way to Treatment?
by Crook, Zachary R
Neuron (Cambridge, Mass.), 2011-02-10, Vol.69 (3), p.423-435
5.
Cognitive domains that predict time to diagnosis in prodromal Huntington disease
by Harrington, Deborah Lynn
Journal of neurology, neurosurgery and psychiatry, 2012-06, Vol.83 (6), p.612-619
6.
Towards a transgenic model of Huntington's disease in a non-human primate
by Chan, Anthony W. S
Nature, 2008-06-12, Vol.453 (7197), p.921-924
7.
The Biology of Huntingtin
by Saudou, Frédéric
Neuron (Cambridge, Mass.), 2016-03-02, Vol.89 (5), p.910-926
8.
Artificial miRNAs Reduce Human Mutant Huntingtin Throughout the Striatum in a Transgenic Sheep Model of Huntington's Disease
by Pfister, Edith L
Human gene therapy, 2018-06-01, Vol.29 (6), p.663-673
9.
Neuronal targets for reducing mutant huntingtin expression to ameliorate disease in a mouse model of Huntington's disease
by Wang, Nan
Nature medicine, 2014-05, Vol.20 (5), p.536-541
10.
The Prevalence of Huntington's Disease
by Rawlins, Michael D
Neuroepidemiology, 2016-03, Vol.46 (2), p.144-153
11.
Critical Roles for Anterior Insula and Dorsal Striatum in Punishment-Based Avoidance Learning
by Palminteri, Stefano
Neuron (Cambridge, Mass.), 2012-12-06, Vol.76 (5), p.998-1009
12.
Longitudinal change in regional brain volumes in prodromal Huntington disease
by Aylward, Elizabeth H
Journal of neurology, neurosurgery and psychiatry, 2011-04, Vol.82 (4), p.405-410
13.
Impaired TrkB Receptor Signaling Underlies Corticostriatal Dysfunction in Huntington’s Disease
by Plotkin, Joshua L
Neuron (Cambridge, Mass.), 2014-07-02, Vol.83 (1), p.178-188
14.
Serines 13 and 16 Are Critical Determinants of Full-Length Human Mutant Huntingtin Induced Disease Pathogenesis in HD Mice
by Gu, Xiaofeng
Neuron (Cambridge, Mass.), 2009-12-24, Vol.64 (6), p.828-840
15.
Trinucleotide repeat disorders
by ORR, Harry T
Annual review of neuroscience, 2007, Vol.30 (1), p.575-621
16.
Huntington’s disease: the coming of age
by Pandey, Mritunjay
Journal of genetics, 2018-07-20, Vol.97 (3), p.649-664
17.
Huntington's disease
by Walker, Francis O, Prof
The Lancet (British edition), 2007, Vol.369 (9557), p.218-228
18.
Huntingtin aggregation and toxicity in Huntington's disease
by Bates, Gillian
The Lancet (British edition), 2003-05-10, Vol.361 (9369), p.1642-1644
19.
Huntington's disease is a four-repeat tauopathy with tau nuclear rods
by Fernandez-Nogales, M
Nature medicine, 2014, Vol.20 (8), p.881-885
20.
Sirt1 mediates neuroprotection from mutant huntingtin by activation of the TORC1 and CREB transcriptional pathway
by Jeong, Hyunkyung
Nature medicine, 2011-12-18, Vol.18 (1), p.159-165
